Article
SLCO4A1 expression is associated with activated inflammatory pathways in high-grade serous ovarian cancer
29 Aug 2022
Abstract excerpt
Patients with high-grade serous ovarian cancer (HGSOC) have a very poor overall survival. Current therapeutic approaches do not bring benefit to all patients. Although genetic alterations and molecular mechanisms are well characterized, the molecular pathological conditions are poorly investigated. Solute carrier organic anion transporter family member 4A1 (SLCO4A1) encodes OATP4A1, which is an uptake membrane...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
